EDWARDS LIFESCIENCES revenue breakdown overview

EDWARDS LIFESCIENCES revenue for the last year amounted to 5.44 B EUR, the most of which — 3.69 B EUR — came from its highest performing source at the moment, Transcatheter Mitral and Tricuspid Therapies, the year earlier bringing 3.40 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought EDWARDS LIFESCIENCES 3.18 B EUR, and the year before that — 2.93 B EUR.